SCHEMBL7036191

SCHEMBL7036191

COC(=O)c1cc(I)ccc1NC(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.57
PPARA Q07869 2/20 0.57
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.53
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
TP53 P04637 3/20 0.52
HDAC1 Q13547 2/20 0.52
HDAC8 Q9BY41 2/20 0.52
HDAC6 Q9UBN7 2/20 0.52
JAK2 O60674 1/20 0.50
JAK1 P23458 1/20 0.50
TYK2 P29597 1/20 0.50
MAPT P10636 2/20 0.48
FLT1 P17948 1/20 0.48
FLT4 P35916 1/20 0.48
KDR P35968 1/20 0.48
LMNA P02545 2/20 0.48
ABL1 P00519 1/20 0.48
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039680 0.88 PPARG (0.59) PPARGPPARAALDH1A1SMN1; SMN2RAB9A
SCHEMBL7034504 0.84 PPARG (0.54) PPARGPPARAALDH1A1SMN1; SMN2RAB9A
SCHEMBL7040693 0.83 PPARG (0.60) PPARGPPARAALDH1A1TP53HDAC8
SCHEMBL7037291 0.82 PPARG (0.52) PPARGPPARAALDH1A1SMN1; SMN2RAB9A
SCHEMBL417476 0.81 SERPINE1 (0.56) ALDH1A1RAB9ANPC1MAPTKDM4E
SCHEMBL7038586 0.81 PPARG (0.61) PPARGPPARAALDH1A1SMN1; SMN2NPC1
SCHEMBL2889149 0.80 TP53 (0.54) PPARGPPARAALDH1A1SMN1; SMN2RAB9A
SCHEMBL7035471 0.79 PPARG (0.49) PPARGPPARAALDH1A1SMN1; SMN2RAB9A
SCHEMBL7036249 0.79 PPARG (0.75) PPARGPPARAALDH1A1SMN1; SMN2RAB9A
SCHEMBL7040714 0.78 PPARG (0.76) PPARGPPARAALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 US disclosed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885ALDH1A1 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.